Claims
- 1. A method for treating a subject suffering from at least one of the symptoms of pain, fever, and tissue and/or bone and joint inflammation, which comprises administering to the subject a pharmaceutical composition which comprises a therapeutically effective amount of at least one compound of the general formula: ##STR223## wherein one of A and B is --CH.sub.3 and the other of A and B is ##STR224## wherein R is a hydrogen atom or a lower alkyl group, Z is selected from the group consisting of (1) a group of the formula ##STR225## wherein X.sub.1 and X.sub.2 are the same or different and each represents a hydrogen atom, a lower alkyl group, a lower alkoxy group, a trifluoromethyl group or a halogen atom; (2) a pyridyl group; and (3) a group of the formula: ##STR226## wherein Y.sub.1 and Y.sub.2 are the same or different and Y.sub.1 and Y.sub.2 are selected from the group consisting of a hydrogen atom, a lower alkyl group, a lower alkoxy group, a trifluoromethyl group and a halogen atom, X is a nitrogen atom or a carbon atom, m is 2 or 3, and n is an integer of from 2 to 10, with the provisos that (i) when A is --CH.sub.3, m is 2, (ii) when A is ##STR227## Z is not pyridyl and X is nitrogen and (iii) when X is nitrogen, m is 3, and acid addition salts thereof, for analgesic, antiphlogistic, and antipyretic purposes, in combination with a pharmaceutically effective carrier.
- 2. A method as claimed in claim 1 in which said subject suffers from pain.
- 3. A method as claimed in claim 1 in which said subject suffers from fever.
- 4. A method as claimed in claim 1 in which said subject suffers from tissue and/or bone and joint inflammation.
- 5. A method as claimed in claim 3, wherein said compound has the formula ##STR228##
- 6. A method as claimed in claim 4, wherein said compound has the formula ##STR229##
- 7. A method as claimed in claim 1, wherein said compound is administered to said subject in a dosage of from 1 to 1,000 mg per day.
- 8. A method as claimed in claim 2, wherein said compound is administered to said subject in a dosage of 1 to 1,000 mg per day.
- 9. A method as claimed in claim 3, wherein said compound is administered to said subject in a dosage of 1 to 1,000 mg per day.
- 10. A method as claimed in claim 4, wherein said compound is administered to said subject in a dosage of 1 to 1,000 mg per day.
- 11. A method according to claim 1 wherein said compound is selected from the group consisting of
- 7-(2-((4-phenyl)piperidinyl)ethyl)theophylline,
- 7-(3-((4-phenyl)piperidinyl)-n-propyl)theophylline,
- 7-(4-((4-phenyl)piperidinyl)-n-butyl)theophylline, and
- 7-(5-((4-p-chlorophenyl)piperidinyl)-n-pentyl)theophylline.
- 12. A method according to claim 1 wherein said compound is
- 1-(4-(4-p-chlorobenzylhomopiperazinyl-(1)-n-butyl)theobromine.
Parent Case Info
This is a division of application Ser. No. 471 564, filed Mar. 2, 1983, now U.S. Pat. No. 4,543,253.
US Referenced Citations (2)
Number |
Name |
Date |
Kind |
4073908 |
Quelet |
Feb 1978 |
|
4275064 |
Bodor et al. |
Jun 1984 |
|
Divisions (1)
|
Number |
Date |
Country |
Parent |
471564 |
Mar 1983 |
|